Oxford Square Capital Corp. (OXSQ) is a Greenwich, Connecticut-based business development company that lends to middle-market and technology-related borrowers and holds equity in collateralized loan obligations. In Monday's session the stock traded at $0.6373, down 15.79% from the prior session's close of $0.76 — a fresh all-time low. The direction is decisively negative. Part of the move is the standard price adjustment for the $0.035 monthly distribution that went ex today, but the majority reflects sustained selling pressure tied to the company's sharply reduced payout, falling net asset value, and persistent dilution from share issuance.
Today marks the ex-dividend date for Oxford Square's $0.035 monthly distribution, payable Nov. 30. On an ex-date, a stock's quoted price drops by roughly the payout amount, so approximately 4.6 percentage points of the 15.79% headline decline are a bookkeeping adjustment rather than lost value. That mechanical component is real but secondary: the shares opened near $0.74 in pre-market trading and then extended losses through the morning, trading roughly 12% below the distribution-adjusted reference level. The selling accelerated rather than stabilized, a pattern consistent with income buyers exiting after the payout reset.
The dominant fundamental catalyst remains the third-quarter report released Oct. 30, which triggered an 18.65% single-day drop and set the current downtrend in motion. Net investment income slipped to $4.9 million, or $0.04 per share, from $5.1 million, or $0.05 per share, in the prior quarter and missed consensus by a penny. Net asset value per share fell to $1.21 from $1.29 as realized and unrealized investment losses widened to $3.3 million, including losses on two CLO equity positions that reached their end points.
More damaging for a yield-driven shareholder base, the board declared monthly distributions of just $0.015 per share for January, February and March 2027, down from the $0.035 monthly rate — a reduction of roughly 57% to an annualized $0.18 per share. The company also issued 14.1 million shares for $19.4 million in net proceeds through an at-the-market program, growing the share count more than 30% year over year. At the current price the stock trades near a 47% discount to its last reported NAV, a valuation that signals investors expect further book-value erosion.
Oxford Square's portfolio leans on syndicated loans and the riskiest CLO equity tranches, a structure highly sensitive to credit conditions. Management noted that the default rate including liability management exercises stood at 2.97% at Sept. 30, up from 2.77% in June, while the distress ratio rose to 7.05% from 6.87%. CCC-rated loan prices fell sharply during the quarter even as the broader leveraged loan index improved. CLO-focused peers have traded similarly weak, and there was no offsetting macro or industry tailwind on Monday — the weakness is segment-specific, not part of a broad market selloff.
Volume has been running above normal for weeks and Monday's tape looks no different: roughly 800,000 shares changed hands in the first part of the session against a three-month average near 1.6 million. The stock has now broken below its previous 52-week low of $0.7580 and sits far under its 50-day moving average, which is near $1.19, and its longer-term averages — a clear technical breakdown rather than a range-bound pullback. The shares have lost about 61% over the past twelve months, with market capitalization down to roughly $77 million.
The score runs from 0, meaning no meaningful news and a normal move for the stock, to 100, meaning transformative news and an extreme, rare price move. Oxford Square earns 51 out of 100. Verified news value is modest: an ex-dividend date plus the tail of a payout cut already disclosed on Oct. 30 is routine rather than transformative for a company of this size.
The price behavior is the stronger component. Monday's 15.79% decline was about 7.6 times the stock's typical absolute daily move of roughly 2.1% over the past 70 sessions, and only one session in that stretch produced a larger move. A large but not unprecedented swing combined with limited fresh news produces a middling score.
The next hard data point is the fourth-quarter report, expected in late January or early February, when investors will see whether NAV stabilized after two consecutive quarterly declines and whether net investment income covers the new $0.045 quarterly payout. Distribution declarations for April 2027 onward will be scrutinized as a signal on earnings power. Credit metrics — the default rate, the distress ratio, and the $6.8 million of preferred equity on non-accrual — matter more than headline income for a portfolio concentrated in CLO equity. Further at-the-market issuance remains a dilution risk, and any widening in leveraged loan spreads would pressure book value again. The stock's wide discount to NAV could attract value buyers, but only if book value stops falling.
Tickeron's Trending AI Robots page showcases a curated selection from hundreds of AI trading bots that cover thousands of tickers. Because the full universe is broad, only the strongest performers under current market conditions are featured in this section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, letting users compare approaches side by side. Review the current leaders to see which automated strategies are working in this market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
OXSQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 76 of 200 cases where OXSQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OXSQ as a result. In 49 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
The Moving Average Convergence Divergence Histogram (MACD) for OXSQ turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 31 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
OXSQ moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OXSQ crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 30%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OXSQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.697) is normal, around the industry mean (2.423). P/E Ratio (-2.032) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.160) settles around the average of (0.274) among similar stocks. OXSQ's P/S Ratio (74.139) is slightly higher than the industry average of (15.906).
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. OXSQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OXSQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a private equity fund
Industry InvestmentManagers